The COVID-19 pandemic has revealed major deficiencies and inequities in the U.S. healthcare system, shining a spotlight on improvements that must be made to steel the country for future disasters, argues Maia Dorsett in an Editorial. “US healthcare is incentivized to react to sickness rather than proactively focus on health maintenance,” Dorsett writes. “As an…
WASHINGTON–The Endocrine Society joined a coalition of leading bone health organizations to release guidance for healthcare professionals treating patients with osteoporosis in the era of COVID-19. The guidelines address the challenges that social distancing has presented for treating patients with osteoporosis, including those who receive treatment through injection or intravenous (IV) delivery of drugs. It…
ROCHESTER, Minn. — Olanzapine, a generic drug used to treat nervous, emotional and mental conditions, also may help patients with advanced cancer successfully manage nausea and vomiting unrelated to chemotherapy. These are the findings of a study published Thursday, May 7 in JAMA Oncology. Charles Loprinzi, M.D., a Mayo Clinic medical oncologist, played a leadership…
Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder receive proven life-saving medications both during and after they’re discharged. The study published in the Journal of General Internal Medicine. “It really paints…
A new data analysis funded by the National Institutes of Health finds patients who visited the emergency department for an opioid overdose are 100 times more likely to die by drug overdose in the year after being discharged and 18 times more likely to die by suicide relative to the general population. Additionally, in the…